4D pharma plc Capital Expenditures
4D pharma plc reported Capital Expenditures of $279.00 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2022-03-31
| Period end | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|
| 2021-12-31 | $279.00K 20-F · filed 2022-03-31 | |
| 2021-06-30 | $161.00K 6-K/A · filed 2022-02-18 | |
| 2020-12-31 | $211.00K 20-F · filed 2022-03-31 | |
| 2020-06-30 | $202.00K 6-K/A · filed 2022-02-18 | |
| 2019-12-31 | $681.00K 20-F · filed 2022-03-31 | |
| 2018-12-31 | $721.00K 20-F/A · filed 2021-04-30 |